A detailed history of Russell Investments Group, Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 53,256 shares of TGTX stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,256
Previous 52,339 1.75%
Holding current value
$1.27 Million
Previous $796,000 18.97%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$13.32 - $19.19 $12,214 - $17,597
917 Added 1.75%
53,256 $947,000
Q1 2024

May 08, 2024

BUY
$13.02 - $21.3 $389,597 - $637,359
29,923 Added 133.49%
52,339 $796,000
Q4 2023

Feb 05, 2024

SELL
$6.68 - $18.81 $10,868 - $30,603
-1,627 Reduced 6.77%
22,416 $382,000
Q3 2023

Nov 13, 2023

BUY
$8.36 - $26.5 $167,709 - $531,616
20,061 Added 503.79%
24,043 $200,000
Q2 2023

Aug 10, 2023

BUY
$15.48 - $35.0 $40,248 - $91,000
2,600 Added 188.13%
3,982 $98,000
Q1 2023

May 09, 2023

SELL
$10.23 - $19.34 $299,442 - $566,101
-29,271 Reduced 95.49%
1,382 $20,000
Q4 2022

Feb 08, 2023

BUY
$5.01 - $11.83 $27,059 - $63,893
5,401 Added 21.39%
30,653 $362,000
Q3 2022

Nov 04, 2022

BUY
$4.57 - $8.4 $115,401 - $212,116
25,252 New
25,252 $148,000
Q2 2022

Jul 29, 2022

SELL
$3.74 - $10.66 $4,334 - $12,354
-1,159 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$7.81 - $20.45 $288,064 - $754,277
-36,884 Reduced 96.95%
1,159 $11,000
Q4 2021

Jan 21, 2022

SELL
$15.2 - $35.51 $149,355 - $348,921
-9,826 Reduced 20.53%
38,043 $722,000
Q3 2021

Nov 08, 2021

SELL
$21.78 - $40.45 $173,608 - $322,426
-7,971 Reduced 14.27%
47,869 $1.59 Million
Q2 2021

Aug 04, 2021

SELL
$32.5 - $48.96 $1.08 Million - $1.62 Million
-33,110 Reduced 37.22%
55,840 $2.16 Million
Q1 2021

May 10, 2021

SELL
$41.61 - $54.3 $1.54 Million - $2.01 Million
-37,013 Reduced 29.38%
88,950 $4.29 Million
Q4 2020

Feb 08, 2021

BUY
$25.27 - $54.9 $50,110 - $108,866
1,983 Added 1.6%
125,963 $6.55 Million
Q3 2020

Nov 09, 2020

BUY
$18.49 - $27.24 $2.08 Million - $3.06 Million
112,471 Added 977.24%
123,980 $3.31 Million
Q2 2020

Aug 05, 2020

BUY
$8.9 - $21.84 $102,430 - $251,356
11,509 New
11,509 $224,000
Q1 2018

May 11, 2018

SELL
$8.7 - $16.8 $114,918 - $221,911
-13,209 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$10.0 - $12.7 $132,090 - $167,754
13,209
13,209 $157,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.